Representatives from 22nd Century Group will ring the closing bell on Nasdaq on August 26, 2022 to celebrate the launch of VLN, a reduced nicotine tobacco product.
Image: Mat Szymański
In December 2021, the U.S. Food and Drug Administration authorized 22nd Century Group to sell VLN cigarettes as a reduced-risk tobacco product. VLN cigarettes are the first combustible cigarettes to receive this approval.
Since then, the company has launched its VLN cigarettes in various test markets, including the Chicago area. According to 22nd Century Group, the Chicago test exceeded expectations, prompting the company to accelerate the expansion of its market to Colorado.
John J stated, "Our VLN pilot program in Chicago has confirmed the market's interest in VLN, as adult smokers are seeking new tools to help them reduce smoking, which is an important step in improving overall public health." Miller, CEO of 22nd Century Tobacco, explained this in a statement.
Based on the better-than-expected results of our pilot program, we are accelerating our plans to expand our market and begin selling through multiple partnership channels in Colorado. These partners are committed to helping us provide a genuine tobacco harm reduction option for adult smokers.
Statement
This article is compiled from third-party information and is intended for industry communication and learning purposes only.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's contents. The translation of this article is only intended for industry exchange and research.
Due to limitations in the translation process, the translated article may not accurately reflect the original text. Please refer to the original article for accuracy.
In regards to any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions, 2FIRSTS maintains complete alignment with the Chinese government.
Information compiled is the intellectual property of the original media and its respective author. If there is any infringement, please contact us for removal.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
